Cargando…
A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
PURPOSE: To assess the relative cost-effectiveness of cascade genetic testing in asymptomatic relatives of patients with dilated cardiomyopathy (DCM) compared with periodical clinical surveillance. METHODS: A decision-analytic model, combining a decision tree and a Markov model, was used to determin...
Autores principales: | Catchpool, Max, Ramchand, Jay, Martyn, Melissa, Hare, David L., James, Paul A., Trainer, Alison H., Knight, Josh, Goranitis, Ilias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892743/ https://www.ncbi.nlm.nih.gov/pubmed/31222143 http://dx.doi.org/10.1038/s41436-019-0582-2 |
Ejemplares similares
-
Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy
por: Ramchand, Jay, et al.
Publicado: (2020) -
Cost Analysis of Orthoptist-Led Neurofibromatosis Type 1 Screening Clinics
por: Kaur, Navdeep, et al.
Publicado: (2023) -
Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006) -
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
por: Jayasinghe, Kushani, et al.
Publicado: (2021) -
Genetic Variations Leading to Familial Dilated Cardiomyopathy
por: Cho, Kae Won, et al.
Publicado: (2016)